Rehmann Capital Advisory Group’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$280K Buy
3,666
+357
+11% +$25.7K 0.01% 568
2025
Q4
$212K Buy
+3,309
New +$204K 0.01% 623
2024
Q4
Sell
-1,790
Closed -$202K 608
2024
Q3
$202K Buy
+1,790
New +$179K 0.01% 574
2019
Q3
$54.6K Buy
738
+40
+6% +$2.87K 0.01% 595
2019
Q2
$54.4K Sell
698
-321
-32% -$24.4K 0.01% 800
2019
Q1
$77.4K Buy
1,019
+685
+205% +$54.4K 0.01% 673
2018
Q4
$24.4K Sell
334
-302
-47% -$24.1K ﹤0.01% 809
2018
Q3
$60.9K Sell
636
-73
-10% -$7.24K 0.01% 731
2018
Q2
$70.9K Buy
709
+409
+136% +$43.2K 0.01% 668
2018
Q1
$32K Buy
+300
New +$30.3K 0.01% 909

Other funds holding EMN

Rehmann Capital Advisory Group's EMN Position: Q1 2026 in Review

Rehmann Capital Advisory Group increased its Eastman Chemical (EMN) stake by 11% in Q1 2026, buying an estimated $25.7K and bringing the position to 3,666 shares worth $280K. The position accounts for 0.01% of the portfolio, ranked #568.

Rehmann Capital Advisory Group first reported a position in EMN in Q1 2018 and has held it in 10 quarters since. 635 funds tracked by Wall St. Rank hold EMN as of Q1 2026.

  • Rehmann Capital Advisory Group held 3,666 shares of Eastman Chemical worth $280K as of Q1 2026.
  • Rehmann Capital Advisory Group bought 357 Eastman Chemical shares in Q1 2026, an estimated $25.7K.
  • Eastman Chemical made up 0.01% of Rehmann Capital Advisory Group's portfolio in Q1 2026, its #568 holding.
  • Rehmann Capital Advisory Group first reported a position in Eastman Chemical in Q1 2018 and has held it in 10 quarters since.
  • 635 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2026.

Based on Rehmann Capital Advisory Group's 13F filing for Q1 2026, filed 15 May 2026.